THIOTEPA Side Effects

6532052-7 | Bilirubin Conjugated Increased, Blood Bilirubin Abnormal, Device Related Infection, Gamma-glutamyltransferase Increased, Leukopenia, Musculoskeletal Stiffness, Neutrophil Count Abnormal, Platelet Count Decreased
on Jan 07, 2010 Female patient from UNITED STATES , weighting 14.95 lb, was treated with Thiotepa (View Usage). Patient experienced the following unwanted or unexpected effects: bilirubin conjugated increased, blood bilirubin abnormal, device related infection, gamma-glutamyltransferase increased, leukopenia, musculoskeletal stiffness, neutrophil count abnormal, platelet count decreased. Thiotepa dosage: 134 Mg. During the same period patient was treated with METHOTREXATE (2.5 Mg) (View Methotrexate Review and Methotrexate Label ), CARBOPLATIN (230 Mg) (View Carboplatin Review and Carboplatin Label ), AMBISOME (View Ambisome Review and Ambisome Label ), ATIVAN (View Ativan Review and Ativan Label ), BOSENTAN (View Bosentan Review and Bosentan Label ), CHLORAL HYDRATE (View Chloral Hydrate Review and Chloral Hydrate Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

6160540-4 | Cardiac Failure, Hepatic Failure, Hypertension, Mucosal Inflammation, Multi-organ Failure, Neutropenia, Pyrexia, Respiratory Failure
Patient was taking Thiotepa (View Usage). Patient had the following side effects: cardiac failure, hepatic failure, hypertension, mucosal inflammation, multi-organ failure, neutropenia, pyrexia, respiratory failure on Apr 15, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 37.04 lb, . Thiotepa dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

6046035-7 | Areflexia, Asthenia, Hypoaesthesia, Malignant Neoplasm Progression
Adverse event was reported on Jan 06, 2009 by a Female patient taking Thiotepa (View Usage) (Dosage: ) was diagnosed with bone marrow transplant (What is bone marrow transplant?) and. Location: UNITED STATES , child 12 years of age, After Thiotepa was administered, patient had the following side effects: areflexia, asthenia, hypoaesthesia, malignant neoplasm progression. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

5737344-7 | Blister
on May 03, 2007 Female patient from UNITED STATES , 40 years of age, was treated with Thiotepa (View Usage). Patient experienced the following unwanted or unexpected effects: blister. Thiotepa dosage: .


5355359-8 | Abdominal Pain, Burning Sensation
on Feb 22, 2007 Female patient from UNITED STATES , 60 years of age, weighting 352.7 lb, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Thiotepa (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), burning sensation. Thiotepa dosage: 30 Mg/60 Ml Sterile Water/intr.

5341812-X | Venous Occlusion
Patient was taking Thiotepa (View Usage). After Thiotepa was administered, patient had the following side effects: venous occlusion on May 29, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 25.79 lb, was diagnosed with medulloblastoma and. Thiotepa dosage: 115mg-thio- Daily X 3 Days Iv. During the same period patient was treated with ETOPOSIDE (95mg Daily X 3 Days Iv) (View Etoposide Review and Etoposide Label ), CARBOPLATIN (190mg Daily X 3 Days Iv) (View Carboplatin Review and Carboplatin Label ), TYLENOL (View Tylenol Review and Tylenol Label ), MORHPINE (View Morhpine Review and Morhpine Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ). Patient was hospitalized.

4810187-4 | Csf Test Abnormal, Cytology Abnormal, Headache, Post Procedural Complication
Adverse event was reported on Oct 25, 2005 by a Male patient taking Thiotepa (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 151.7 lb, Patient experienced the following unwanted or unexpected effects: csf test abnormal, cytology abnormal, headache (What is headache?), post procedural complication.

4754527-3 | Bone Marrow Transplant, Complications Of Bone Marrow Transplant, Respiratory Failure, Venoocclusive Disease
on Aug 25, 2005 Female patient from UNITED STATES , weighting 22.05 lb, was diagnosed with medulloblastoma and was treated with Thiotepa (View Usage). Patient had the following side effects: bone marrow transplant (What is bone marrow transplant?), complications of bone marrow transplant, respiratory failure, venoocclusive disease. Thiotepa dosage: 10 Mg/kg Daily X 3 Iv. During the same period patient was treated with CARBOPLATIN (16.7 Mg/kg Daily X 3 Iv) (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

4738675-X | Abdominal Distension, Ascites, Blood Bilirubin Increased, Lung Infiltration, Respiratory Distress, Venous Occlusion
on Aug 09, 2005 Female patient from UNITED STATES , weighting 22.05 lb, was diagnosed with medulloblastoma and was treated with Thiotepa (View Usage). After Thiotepa was administered, patient had the following side effects: abdominal distension, ascites, blood bilirubin increased, lung infiltration, respiratory distress, venous occlusion. Thiotepa dosage: 10 Mg/kg Daily X 3doses Intravenou. During the same period patient was treated with CARBOPLATIN (16.7 Mg/kg Daily X 3dose Intravenou) (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), ZOSYN (View Zosyn Review and Zosyn Label ), GENT (View Gent Review and Gent Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), TPN/INTRALIPIDS (View Tpn/intralipids Review and Tpn/intralipids Label ).